C11ORF54 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.474400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.587600E-01
Normal-vs-Stage2
9.252400E-01
Normal-vs-Stage3
2.495400E-01
Normal-vs-Stage4
7.023600E-01
Stage1-vs-Stage2
3.764800E-01
Stage1-vs-Stage3
1.835620E-01
Stage1-vs-Stage4
6.629800E-01
Stage2-vs-Stage3
1.914770E-01
Stage2-vs-Stage4
4.202000E-01
Stage3-vs-Stage4
1.526980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.618000E-01
Normal-vs-AfricanAmerican
4.426800E-01
Normal-vs-Asian
5.875000E-01
Caucasian-vs-AfricanAmerican
2.276600E-01
Caucasian-vs-Asian
5.421600E-01
AfricanAmerican-vs-Asian
1.801210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.329800E-01
Normal-vs-Female
9.873000E-01
Male-vs-Female
4.108400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.254400E-01
Normal-vs-Age(41-60Yrs)
8.931400E-01
Normal-vs-Age(61-80Yrs)
7.548000E-01
Normal-vs-Age(81-100Yrs)
9.864200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.973600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.195600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.516200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.601610E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.036400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.604400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.883800E-01
Normal-vs-Daily Drinker
5.544400E-01
Normal-vs-Weekly Drinker
3.903200E-01
Normal-vs-Occasional Drinker
9.561400E-01
Normal-vs-Social Drinker
8.179000E-01
Non Drinker-vs-Daily Drinker
3.874400E-01
Non Drinker-vs-Weekly Drinker
1.476220E-01
Non Drinker-vs-Occasional Drinker
7.109000E-01
Non Drinker-vs-Social Drinker
9.875400E-01
Daily Drinker-vs-Weekly Drinker
5.387400E-01
Daily Drinker-vs-Occasional Drinker
3.193800E-01
Daily Drinker-vs-Social Drinker
4.768800E-01
Weekly Drinker-vs-Occasional Drinker
1.607380E-01
Weekly Drinker-vs-Social Drinker
2.258400E-01
Occasional Drinker-vs-Social Drinker
7.749200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.653550E-01
Normal-vs-Grade 2
6.045600E-02
Normal-vs-Grade 3
5.234100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.205000E-01
Grade 1-vs-Grade 3
3.931600E-01
Grade 1-vs-Grade 4
1.653550E-01
Grade 2-vs-Grade 3
2.500000E-01
Grade 2-vs-Grade 4
6.045600E-02
Grade 3-vs-Grade 4
5.234100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.515400E-01
Normal-vs-NonDiabetic
8.181000E-01
Diabetic-vs-NonDiabetic
1.894820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.537000E-01
Normal-vs-NoPancreatitis
7.431200E-01
Pancreatitis-vs-NoPancreatitis
4.388600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.451400E-01
Normal-vs-N1
9.967800E-01
N0-vs-N1
7.893800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.701200E-01
Normal-vs-TP53-NonMutant
7.230200E-01
TP53-Mutant-vs-TP53-NonMutant
9.559000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
